Catalyst Wire Dossier Catalyst Wire Dossier

HIP2503

· Hanmi Pharmaceutical Company Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HIP2503, covering 2025-12-22 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety Between HIP2503 and HCP1306 in Healthy Volunteers [Phase 1]

See pricing